GeneTether Therapeutics Inc.
GeneTether Therapeutics Inc.
Your view on GTTX.CN
Overview
What the company does, where it operates, and who runs it.
About GeneTether Therapeutics Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Roland Boivin
- Headquarters
- CA
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Roland Boivin
- Headquarters
- CA
GeneTether Therapeutics Inc., a genetic medicines company, focuses on developing gene editing therapies to enhance the efficiency of genome editing technologies. It is developing gene therapies for the treatment of patients with rare and monogenic kidney and skin diseases. The company was founded in 2018 and is based in Kelowna, Canada.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.